These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31461716)

  • 21. Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis.
    Nishiwaki N; Noma K; Kunitomo T; Hashimoto M; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
    Esophagus; 2022 Oct; 19(4):626-638. PubMed ID: 35792947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of incomplete neoadjuvant chemotherapy on esophageal carcinoma.
    Fujiwara Y; Lee S; Kishida S; Hashiba R; Gyobu K; Naka R; Nishiyama M; Ihara T; Takemura M; Osugi H
    Int J Clin Oncol; 2018 Oct; 23(5):877-885. PubMed ID: 29752605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.
    Miyawaki Y; Nakajima Y; Kawada K; Okada T; Tokairin Y; Kawano T
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27001629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-infiltrating lymphocytes in patients undergoing esophagectomy following neoadjuvant DCF therapy.
    Takahashi K; Sakashita Y; Murahashi M; Kubota H; Shimoda M; Ishikawa Y; Tanishima Y; Kurogochi T; Yano F; Eto K
    J Surg Oncol; 2024 Mar; 129(4):700-707. PubMed ID: 38031881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
    Yokota T; Kato K; Hamamoto Y; Tsubosa Y; Ogawa H; Ito Y; Hara H; Ura T; Kojima T; Chin K; Hironaka S; Kii T; Kojima Y; Akutsu Y; Matsushita H; Kawakami K; Mori K; Makiuchi T; Nagumo R; Kitagawa Y
    Ann Surg Oncol; 2020 Feb; 27(2):460-467. PubMed ID: 31376034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer.
    Sugase T; Sugimura K; Kanemura T; Takeoka T; Yamamoto M; Shinno N; Hara H; Omori T; Fujii Y; Mukai Y; Mikamori M; Hasegawa S; Haraguchi N; Akita H; Nishimura J; Wada H; Matsuda C; Yasui M; Miyata H
    Oncology; 2022; 100(12):655-665. PubMed ID: 36198297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis.
    Akiyama Y; Sasaki A; Endo F; Nikai H; Amano S; Umemura A; Baba S; Chiba T; Kimura T; Takahara T; Nitta H; Otsuka K; Mizuno M; Kimura Y; Koeda K; Iwaya T
    World J Surg Oncol; 2018 Jul; 16(1):122. PubMed ID: 29966526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma.
    Murakami Y; Hamai Y; Emi M; Hihara J; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Kimura T; Okada M; Nagata Y
    J Radiat Res; 2018 Sep; 59(5):616-624. PubMed ID: 29939306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ypN0 in Patients With Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer.
    Yoshida T; Nishino T; Goto M; Inoue S; Fujiwara S; Takizawa H; Tangoku A; Uehara H; Bando Y
    Anticancer Res; 2022 Jan; 42(1):195-203. PubMed ID: 34969725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-esophagectomy Adjuvant Chemotherapy Benefits Esophageal Cancer Patients.
    Sohda M; Saito H; Kuriyama K; Yoshida T; Kumakura Y; Honjyo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Sakai M; Miyazaki T; Fukuchi M; Kuwano H
    In Vivo; 2019; 33(2):501-506. PubMed ID: 30804133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of lymphovascular invasion in esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy followed by esophagectomy.
    Oguma J; Ishiyama K; Kurita D; Kanematsu K; Kubo K; Utsunomiya D; Yamamoto S; Honma Y; Kato K; Daiko H
    Esophagus; 2023 Apr; 20(2):215-224. PubMed ID: 36565340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of time to postoperative recurrence on the prognosis of patients with esophageal cancer post recurrence: exploratory analysis of OGSG 1003.
    Hori S; Yamasaki M; Yamamoto N; Harino T; Momose K; Yamashita K; Tanaka K; Sugimura K; Makino T; Takeno A; Shiraishi O; Motoori M; Miyata H; Kimura Y; Hirao M; Yasuda T; Yano M; Doki Y
    Esophagus; 2024 Oct; 21(4):472-483. PubMed ID: 39174706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A Case of Esophageal Cancer Achieving a Pathological Complete Response after Preoperative Docetaxel, Cisplatin, and 5-Fluorouracil Therapy].
    Motegi D; Ichikawa H; Kano Y; Hanyu T; Ishikawa T; Usui K; Sakai T; Hirose Y; Miura K; Nagahashi M; Shimada Y; Sakata J; Kobayashi T; Kameyama H; Wakai T
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2192-2194. PubMed ID: 32156875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docetaxel+Cisplatin+5-FU (DCF) Therapy as a Preoperative Chemotherapy to Advanced Esophageal Squamous Cell Carcinoma: A Single-center Retrospective Cohort Study.
    Umeki Y; Matsuoka H; Fujita M; Goto A; Serizawa A; Nakamura K; Akimoto S; Nakauchi M; Tanaka T; Shibasaki S; Inaba K; Uyama I; Suda K
    Intern Med; 2023; 62(3):319-325. PubMed ID: 36725064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma.
    Hiraki Y; Kimura Y; Imano M; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Makino T; Motoori M; Yamasaki M; Miyata H; Satou T; Satoh T; Furukawa H; Yano M; Doki Y; Yasuda T
    Surg Today; 2021 Jan; 51(1):118-126. PubMed ID: 32596796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.
    Nakajima M; Muroi H; Kikuchi M; Takahashi M; Ihara K; Shida Y; Kurayama E; Ogata H; Yamaguchi S; Sasaki K; Sakai M; Sohda M; Miyazaki T; Kuwano H; Kato H
    Anticancer Res; 2018 Feb; 38(2):911-918. PubMed ID: 29374720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional Effects of Docetaxel on Neoadjuvant Radiotherapy With Cisplatin/5-Fluorouracil for Esophageal Squamous Cell Carcinoma.
    Sasaki K; Tsuruda Y; Shimonosono M; Noda M; Uchikado Y; Arigami T; Matsushita D; Mori S; Nakajo A; Kurahara H; Ohtsuka T
    Anticancer Res; 2022 Aug; 42(8):3905-3911. PubMed ID: 35896244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year Outcomes of Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Oesophagectomy in Oesophageal Cancer.
    Tanishima Y; Nishikawa K; Arakawa Y; Matsumoto A; Yuda M; Tanaka Y; Mitsumori N; Yanaga K
    Anticancer Res; 2020 Oct; 40(10):5829-5835. PubMed ID: 32988912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.